| |
Scientists are increasingly aware that this bench-to-bedside approach to translational research is really a two-way street. Basic scientists provide clinicians with new tools for use in patients and for assessment of their impact, and clinical researchers make novel observations about the nature and progression of disease that often stimulate basic investigations. Translational research has proven to be a powerful process that drives the clinical research engine, however, biotech and pharmaceutical companies are often limited by their access to high quality patient specimen and necessary research tools, and cannot fully explore the potential of translational research. To facilitate our customers to fully explore the potential of translational reserch, we have established a proprietary platform, HuPrimeTM, which helps our customers to Prioritize lead compounds in predictive assays |
|
